[HTML][HTML] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - …, 2020 - thelancet.com
Background Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

[HTML][HTML] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - EClinicalMedicine, 2020 - Elsevier
Background Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - …, 2020 - europepmc.org
Background Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - 2020 - cmuir.cmu.ac.th
CMU Intellectual Repository: Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18
human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A …

[PDF][PDF] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15 …

N Folschweiller, JC Teixeira, S Joshi… - …, 2020 - repositorio.usp.br
Background: Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

[HTML][HTML] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - …, 2020 - ncbi.nlm.nih.gov
Background Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - 2020 - arca.fiocruz.br
Background: Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 …

N Folschweiller, J Teixeira, S Joshi… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

[PDF][PDF] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - researchgate.net
Background: Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …

[PDF][PDF] Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged …

N Folschweiller, J Teixeira, S Joshi, LZ Goldani… - researchgate.net
Background: Women living with HIV (WLWH) are at higher risk of acquisition and
progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination …